NuCana Research Development from 2010 to 2026
| NCNA Stock | USD 2.25 0.03 1.35% |
Research Development | First Reported 2015-12-31 | Previous Quarter 7.1 M | Current Value 2.2 M | Quarterly Volatility 3.2 M |
Check NuCana PLC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NuCana PLC's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Depreciation And Amortization of 370.6 K or Interest Expense of 1.2 M, as well as many indicators such as Price To Sales Ratio of 275.8 K, Dividend Yield of 0.0 or PTB Ratio of 207. NuCana financial statements analysis is a perfect complement when working with NuCana PLC Valuation or Volatility modules.
NuCana | Research Development | Build AI portfolio with NuCana Stock |
Analyzing NuCana PLC's Research Development over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Research Development has evolved provides context for assessing NuCana PLC's current valuation and future prospects.
Latest NuCana PLC's Research Development Growth Pattern
Below is the plot of the Research Development of NuCana PLC over the last few years. It is NuCana PLC's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NuCana PLC's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
NuCana Research Development Regression Statistics
| Arithmetic Mean | 14,811,515 | |
| Geometric Mean | 1,704,281 | |
| Coefficient Of Variation | 84.86 | |
| Mean Deviation | 10,599,335 | |
| Median | 17,673,000 | |
| Standard Deviation | 12,569,485 | |
| Sample Variance | 158T | |
| Range | 36.8M | |
| R-Value | 0.81 | |
| Mean Square Error | 57.7T | |
| R-Squared | 0.66 | |
| Significance | 0.000078 | |
| Slope | 2,018,654 | |
| Total Sum of Squares | 2527.9T |
NuCana Research Development History
About NuCana PLC Financial Statements
NuCana PLC stakeholders use historical fundamental indicators, such as NuCana PLC's Research Development, to determine how well the company is positioned to perform in the future. Although NuCana PLC investors may analyze each financial statement separately, they are all interrelated. For example, changes in NuCana PLC's assets and liabilities are reflected in the revenues and expenses on NuCana PLC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in NuCana PLC. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 20.7 M | 21 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether NuCana PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NuCana PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nucana Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nucana Plc Stock:Check out the analysis of NuCana PLC Correlation against competitors. For information on how to trade NuCana Stock refer to our How to Trade NuCana Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NuCana PLC. Anticipated expansion of NuCana directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive NuCana PLC assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding NuCana PLC requires distinguishing between market price and book value, where the latter reflects NuCana's accounting equity. The concept of intrinsic value - what NuCana PLC's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push NuCana PLC's price substantially above or below its fundamental value.
It's important to distinguish between NuCana PLC's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NuCana PLC should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, NuCana PLC's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.